Get startedLog in
    Picture of Ondine Biomedical logo

    OBI — Ondine Biomedical Cashflow Statement

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Ondine Biomedical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

    2009
    December 31st
    2010
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    CAS
    CAS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-4.6-3.26-50.1-19.4-14.4
    Depreciation
    Non-Cash Items0.56-0.06736.92.410.442
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital0.3450.3060.1470.125-0.27
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Payable / Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-3.44-2.72-12.5-16.3-13.7
    Capital Expenditures-0.001-0.18-0.077-0.311-0.177
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items1.760.665———
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Cash from Investing Activities1.760.485-0.077-0.311-0.177
    Financing Cash Flow Items——-1.17-0.023-0.7
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities1.72.0641.9-0.2753.79
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.023-0.17929.2-16.6-10.1